Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Panobinostat × Clear all

Phase

Status

Completed 38 Terminated 30 Unknown 5 Withdrawn 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Radiotherapy 291 Specimen Handling 286 Magnetic Resonance Spectroscopy 285 pembrolizumab 271 Cyclophosphamide 257 Cisplatin 232 Carboplatin 216 Blood Specimen Collection 214 Drug Therapy 203 Biopsy 172 Gemcitabine 160 Bevacizumab 157 venetoclax 156 Radiosurgery 151 fludarabine 143 Oxaliplatin 141 Nivolumab 139 Capecitabine 139 Paclitaxel 133 Standard of Care 122 Surgical Procedures, Operative 119 Fluorouracil 114 Surveys and Questionnaires 112 Dexamethasone 112 Docetaxel 102 tislelizumab 98 Rituximab 98 Radiation 97 Cytarabine 94 durvalumab 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05725200 2023-02-21

EVIDENT

Oslo University Hospital

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡